Epidemiology, definition and treatment of complicated urinary tract infections
- PMID: 32843751
- DOI: 10.1038/s41585-020-0362-4
Epidemiology, definition and treatment of complicated urinary tract infections
Abstract
UTIs are amongst the most frequent bacterial infections. However, the clinical phenotypes of UTI are heterogeneous and range from rather benign, uncomplicated infections to complicated UTIs (cUTIs), pyelonephritis and severe urosepsis. Stratification of patients with UTIs is, therefore, important. Several classification systems exist for the description and classification of UTIs, with the common rationale that cUTIs have a higher risk of recurrence or chronification, progression or severe outcome than uncomplicated UTIs. The pathophysiology and treatment of cUTIs and pyelonephritis are driven more by host factors than by pathogen attributes. cUTIs and pyelonephritis are associated with high antimicrobial resistance rates among causative pathogens. However, antimicrobial resistance rates can differ substantially, depending on the population being studied and whether the data being analysed are from surveillance studies, registry data or interventional studies, in which specific inclusion and exclusion criteria are used for patient selection. For example, antibiotic resistance rates are higher in patients with urosepsis than in those with less severe infections. Thus, treatment outcomes differ substantially among studies, ranging from 50% to almost 100% clearance of infection, depending on the patient population analysed, the UTI entities included and the primary outcome of the study. Pyelonephritis and cUTIs have emerged as infection models for the study of novel antibiotics, including extensive investigation of novel substances active against Gram-negative bacteria.
Similar articles
-
[Complicated urinary tract infections].Urologe A. 2020 Dec;59(12):1480-1485. doi: 10.1007/s00120-020-01343-1. Urologe A. 2020. PMID: 33025113 Review. German.
-
[Urinary tract infections including pyelonephritis].Med Klin Intensivmed Notfmed. 2023 Sep;118(6):464-469. doi: 10.1007/s00063-023-01034-7. Epub 2023 Jun 16. Med Klin Intensivmed Notfmed. 2023. PMID: 37328667 Review. German.
-
[New antibiotics for the treatment of urinary tract infections].Urologie. 2023 Jul;62(7):705-710. doi: 10.1007/s00120-023-02121-5. Epub 2023 Jun 12. Urologie. 2023. PMID: 37306723 Review. German.
-
Current issues in the management of urinary tract infections: extended-release ciprofloxacin as a novel treatment option.Drugs. 2004;64(6):611-28. doi: 10.2165/00003495-200464060-00004. Drugs. 2004. PMID: 15018591 Review.
-
[Urinary tract infections].Aktuelle Urol. 2014 Mar;45(2):135-45; quiz 146. doi: 10.1055/s-0034-1368176. Epub 2014 Apr 3. Aktuelle Urol. 2014. PMID: 24700070 Review. German.
Cited by
-
Comprehensive insights into UTIs: from pathophysiology to precision diagnosis and management.Front Cell Infect Microbiol. 2024 Sep 24;14:1402941. doi: 10.3389/fcimb.2024.1402941. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39380727 Free PMC article. Review.
-
UNAM-HIMFG Bacterial Lysate Activates the Immune Response and Inhibits Colonization of Bladder of Balb/c Mice Infected with the Uropathogenic CFT073 Escherichia coli Strain.Int J Mol Sci. 2024 Sep 12;25(18):9876. doi: 10.3390/ijms25189876. Int J Mol Sci. 2024. PMID: 39337365 Free PMC article.
-
[What is confirmed in therapy of complicated urinary tract infections].Inn Med (Heidelb). 2024 Sep 27. doi: 10.1007/s00108-024-01792-2. Online ahead of print. Inn Med (Heidelb). 2024. PMID: 39331061 Review. German.
-
Lodestar DX, an evaluation: loop-mediated isothermal amplification (LAMP) for the diagnosis of urinary tract infection in symptomatic adult females.JAC Antimicrob Resist. 2024 Sep 17;6(5):dlae148. doi: 10.1093/jacamr/dlae148. eCollection 2024 Oct. JAC Antimicrob Resist. 2024. PMID: 39291181 Free PMC article.
-
Variability in Profiles and Prevalences of Gram-Negative Bacteria in Urinary Tract Infections: A Population-Based Analysis.J Clin Med. 2024 Sep 7;13(17):5311. doi: 10.3390/jcm13175311. J Clin Med. 2024. PMID: 39274523 Free PMC article.
References
-
- Foxman, B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect. Dis. Clin. North Am. 28, 1–13 (2014). - PubMed
-
- Nicolle, L. E. et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin. Infect. Dis. 40, 643–654 (2005). - PubMed
-
- Wagenlehner, F. M., Tandogdu, Z. & Bjerklund Johansen, T. E. An update on classification and management of urosepsis. Curr. Opin. Urol. 27, 133–137 (2017). - PubMed
-
- Tandogdu, Z., Cai, T., Koves, B., Wagenlehner, F. & Bjerklund-Johansen, T. E. Urinary tract infections in immunocompromised patients with diabetes, chronic kidney disease, and kidney transplant. Eur. Urol. Focus. 2, 394–399 (2016). - PubMed
-
- Tenke, P., Koves, B. & Johansen, T. E. An update on prevention and treatment of catheter-associated urinary tract infections. Curr. Opin. Infect. Dis. 27, 102–107 (2014). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical